Skip to content

Key interindividual determinants in MDMA pharmacodynamics

Esther Papaseit, Marta Torrens, Clara Pérez‐mañá, Roberto Muga, Magı́ Farré

Expert Opinion on Drug Metabolism & Toxicology January 5, 2018 DOI: 10.1080/17425255.2018.1424832 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Topics MDMA Mescaline
Keywords Pharmacodynamics Euphoriant Pharmacology Drug Amphetamine Hallucinogen
Citations 20
Key findings Acute MDMA effects are more pronounced in women than in men.

Abstract

MDMA, 3,4-methylenedioxymethamphetamine, is a synthetic phenethylamine derivative with structural and pharmacological similarities to both amphetamines and mescaline. MDMA produces characteristic amphetamine-like actions (euphoria, well-being), increases empathy, and induces pro-social effects that seem to motivate its recreational consumption and provide a basis for its potential therapeutic use. Areas covered: The aim of this review is to present the main interindividual determinants in MDMA pharmacodynamics. The principal sources of pharmacodynamic variability are reviewed, with special emphasis on sex-gender, race-ethnicity, genetic differences, interactions, and MDMA acute toxicity, as well as possible therapeutic use. Expert opinion: Acute MDMA effects are more pronounced in women than they are in men. Very limited data on the relationship between race-ethnicity and MDMA effects are available. MDMA metabolism includes some polymorphic enzymes that can slightly modify plasma concentrations and effects. Although a considerable number of studies exist about the acute effects of MDMA, the small number of subjects in each trial limits evaluation of the different interindividual factors and does not permit a clear conclusion about their influence. These issues should be considered when studying possible MDMA therapeutic use.

Explore topics